Target intelligence / Profile preview

Pathogenic gastrointestinal bacteria

Molecular classification
Bacteria, Prokaryotic organisms, Gram-positive bacteria, Gram-negative bacteria, Anaerobic bacteria, Aerobic bacteria, Facultative bacteria
01

Overview

Pathogenic gastrointestinal bacteria are diverse microorganisms that can colonize and infect the human digestive tract, causing a range of clinical manifestations from mild self-limiting diarrhea to severe, life-threatening conditions. These bacteria employ various virulence mechanisms including toxin production, invasion of intestinal epithelium, and adhesion to mucosal surfaces to cause disease. They can be classified based on their Gram staining properties (positive or negative), oxygen requirements (aerobic, anaerobic, or facultative), and morphology (cocci, bacilli, or spiral-shaped). Common pathogenic gastrointestinal bacteria include Salmonella, Shigella, Campylobacter, pathogenic E. coli strains, Listeria, and Clostridium difficile. Diagnosis typically involves stool culture, molecular testing, or antigen detection, while treatment may include antibiotics, supportive care, and rehydration. Prevention strategies focus on food safety, proper hygiene, and vaccination where available. These bacteria represent important therapeutic targets due to their significant global disease burden, particularly in developing countries and among vulnerable populations.

Other names
Enteric pathogensIntestinal bacterial pathogensGI bacterial pathogensPathogenic enteric bacteria
02

Mechanism of action

Antibiotics: Inhibition of bacterial cell wall synthesis, protein synthesis, or DNA replication; Probiotics: Competitive inhibition of pathogen colonization; Antimotility agents: Reduction of intestinal motility; Antidiarrheal medications: Absorption of water and reduction of fluid loss.

03

Biological functions

Colonization of gastrointestinal tractToxin productionInvasion of intestinal epitheliumAdhesion to mucosal surfacesBiofilm formationImmune evasionNutrient acquisition
04

Disease associations

GastroenteritisDiarrheal diseasesFood poisoningDysenteryEnteric feverInflammatory bowel conditionsSystemic infectionsSepsis
05

Safety considerations

Antibiotic resistanceRecurrent infectionsChronic carrier statesHemolytic uremic syndrome (with certain E. coli strains)Post-infectious complications (reactive arthritis, Guillain-Barré syndrome)Bacterial translocation leading to systemic infection
06

Interacting drugs

Antibiotics (various classes)

4 more in the full profile.

07

Biomarkers

Fecal leukocytesElevated C-reactive proteinStool culture positivitySpecific bacterial antigens in stoolElevated inflammatory markers

Beyond the preview

Go deeper on Pathogenic gastrointestinal bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic gastrointestinal bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call